Private market investing vC and private market investing in

VC and private market investing in biotech surged 11% in H1 2024, driven by breakthroughs in gene-editing patents. Investors project cumulative funding of $50B in the sector this year as FDA regulatory approval timelines shorten. Here's Why Centrus Energy Surged 53.7% in September was originally published by The Motley Fool Information provided by VanEck is not intended to be, nor should it be construed as financial, tax, or legal advice. It is not a recommendation to buy or sell an interest in cryptocurrencies. Private market investing in green hydrogen facilities is receiving multi-billion-dollar backing, with projected returns hitting 15% IRR in long-term infrastructure funds.